Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis

Human Molecular Genetics

Volumn 16, Issue R1, 2007, Pages

  Boikos, Sosipatros A ^a   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AROMATIC HYDROCARBON RECEPTOR INTERACTING PROTEIN; BETA CATENIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH HORMONE RELEASING FACTOR; METHIONINE; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN; PROTEIN KINASE A REGULATORY SUBUNIT 1ALPHA; PROTEIN KINASE C; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; SECURIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ACROMEGALY; ALBRIGHT SYNDROME; CARNEY COMPLEX; CELL CYCLE REGULATION; ENZYME ACTIVATION; FAMILY HISTORY; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOPHYSIS TUMOR; MOLECULAR GENETICS; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; SIGNAL TRANSDUCTION;

ADENOMA; ANIMALS; CELL CYCLE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GROWTH SUBSTANCES; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR BIOLOGY; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; SYNDROME;

MURINAE; RODENTIA;

EID: 34547821490     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm019     Document Type: Review

References (93)

1. Zhuang, Z., Ezzat, S.Z., Vortmeyer, A.O., Weil, R., Oldfield, E.H., Park, W.S., Pack, S., Huang, S., Agarwal, S.K., Guru, S.C. et al. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res., 57, 5446-5451.
2. Boikos, S.A. and Stratakis, C.A. (2006) Pituitary pathology in patients with Carney Complex: Growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary, 9, 203-209.
3. Daly, A.F., Jaffrain-Rea, M.L. and Beckers, A. (2005) Clinical and genetic features of familial pituitary adenomas. Horm. Metab. Res. 37, 347-354.
4. Akintoye, S.O., Chebli, C., Booher, S., Feuillan, P., Kushner, H., Leroith, D., Cherman, N., Bianco, P., Wientroub, S., Robey, P.G. and Collins, M.T. (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J. Clin. Endocrinol. Metab., 87, 5104-5112.
5. Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemi, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Zhuang, Z., Lubensky, I.A., Liotta, L.A. et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science, 276, 404-407.
6. Marx, S.J., Agarwal, S.K., Kester, M.B., Heppner, C., Kim, Y.S., Skarulis, M.C., James, L.A., Goldsmith, P.K., Saggar, S.K., Park, S.Y. et al. (1999) Multiple endocrine neoplasia type 1: Clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog. Horm. Res., 54, 397-439.
7. Agarwal, S.K., Lee Burns, A., Sukhodolets, K.E., Kennedy, P.A., Obungu, V.H., Hickman, A.B., Mullendore, M.E., Whitten, I., Skarulis, M.C., Simonds, W. et al. (2004) Molecular pathology of the MEN1 gene. Ann. N.Y. Acad. Sci., 1014, 189-198.
8. Verges, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C. and Calender, A. (2002) Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study. J. Clin. Endocrinol. Metab., 87, 457-465.
9. Stratakis, C.A., Schussheim, D.H., Freedman, S.M., Keil, M.F., Pack, S.D., Agarwal, S.K., Skarulis, M.C., Weil, R.J., Lubensky, I.A., Zhuang, Z., Oldfield, E.H. and Marx, S.J. (2000) Pituitary macroadenoma in a 5-year-old: An early expression of multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab., 85, 4776-4780.
10. Karhu, A. and Lauri, A.A. (2007) Progress in dissecting hereditary susceptibility to pituitary neoplasia. Hum. Mol. Gen., in press.
11. Boikos, S.A. and Stratakis, C.A. (2007) Carney complex: The first 20 years. Curr. Opin. Oncol., 19, 24-29.
12. Kirschner, L.S., Carney, J.A., Pack, S.D., Taymans, S.E., Giatzakis, C., Cho, Y.S., Cho-Chung, Y.S. and Stratakis, C.A. (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet., 26, 89-92.
13. Bossis, I., Voutetakis, A., Matyakhina, L., Pack, S., Abu-Asab, M., Bourdeau, I., Griffin, K.J., Courcoutsakis, N., Stergiopoulos, S., Batista, D. et al. (2004) A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus. J. Med. Genet., 41, 596-600.
14. Kirschner, L.S., Sandrini, F., Monbo, J., Lin, J.P., Carney, J.A. and Stratakis, C.A. (2000) Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum. Mol. Genet., 9, 3037-3046.
15. Stratakis, C.A., Carney, J.A., Lin, J.P., Papanicolaou, D.A., Karl, M., Kastner, D.L., Pras, E. and Chrousos, G.P. (1996) Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J. Clin. Invest., 97, 699-705.
16. Pack, S.D., Qin, L.X., Pak, E., Wang, Y., Ault, D.O., Mannan, P., Jaikumar, S., Stratakis, C.A., Oldfield, E.H., Zhuang, Z. and Weil, R.J. (2005) Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization. Genes Chromosomes Cancer., 43, 72-82.
17. Stergiopoulos, S.G., Abu-Asab, M.S., Tsokos, M. and Stratakis, C.A. (2004) Pituitary pathology in Carney complex patients. Pituitary, 7, 73-82.
18. Stratakis, C.A., Matyakhina, L., Courkoutsakis, N., Patronas, N., Voutetakis, A., Stergiopoulos, S., Bossis, I. and Carney, J.A. (2004) Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). Front Horm. Res., 32, 253-264.
19. Amieux, P.S., Howe, D.G., Knickerbocker, H., Lee, D.C., Su, T., Laszlo, G.S., Idzerda, R.L. and McKnight, G.S. (2002) Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J. Biol. Chem., 277, 27294-27304.
20. Griffin, K.J., Kirschner, L.S., Matyakhina, L., Stergiopoulos, S.G., Robinson-White, A., Lenherr, S.M., Weinberg, F.D., Claflin, E.S., Batista, D., Bourdeau, I. et al. (2004) A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: Comparison with Carney complex and other PRKAR1A induced lesions. J. Med. Genet., 41, 923-931.
21. Kirschner, L.S., Kusewitt, D.F., Matyakhina, L., Towns, W.H., 2nd., Carney, J.A., Westphal, H. and Stratakis, C.A. (2005) A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res., 65, 4506-4514.
22. Batista, D., Stergiopoulos, S.G., Griffin, K.J., Weinberg, F. and Stratakis, C.A. (2004) Protein Kinase A activity in the pituitary gland of mice expressing the prkar1a antisense construct. Endocrine Society meeting, New Orleans.
23. Batista, D.L., Weinberg, F., Stergiopoulos, S.G., Meoli, E., Griffin, K. and Stratakis, C.A. (2005) Behavior Modifications in mice expressing RI alpha Protein Kinase A subunit mutant. Endocrine Society, San Diego, CA.
24. Pecori Giraldi, F., Mizobuchi, M., Horowitz, Z.D., Downs, T.R., Aleppo, G., Kier, A., Wagner, T., Yun, J.S., Kopchick, J.J. and Frohman, L.A. (1994) Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40T-antigen fusion gene. Endocrinology 134, 1219-1224.
25. Batista, D.L., Weinberg, F., Voutetakis, A., Bossis, I., Kirschner, K., Kineman, R.D. and Stratakis, C.A. (2005) Pituitary pathology in transgenic mice expressing the MThGHRH transgene in the prkar1a ± background. Endocrine Society, San Diego, CA.
26. Batista, D.L., Weinberg, F., Meoli, E., Stergiopoulos, S., Boikos, S., Voutetakis, A., Bossis, I., Kineman, R.D. and Stratakis, C.A. (2006) Pituitary pathology in MT-GHRH/Prkar1a ± mice. Presented in the Annual Endocrinology Meeting, Boston.
27. Kovacs, K., Horvath, E., Thomer, M.O. and Rogol, A.D. (1984) Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virch. Arch. Pathol. Anat., 403, 77-86.
28. Cuttler, L., Jackson, J.A., Uz-Zafar, S., Levitsky, L.L., Mellinger, R.C. and Frohman, L.A. (1989) Hypersecretion of growth hormone and prolactin in McCune-Albfight syndrome. J. Clin. Endocrinol. Metab. 68, 1148-1154.
29. Pack, S.D., Kirschner, L.S., Pak, E., Zhuang, Z., Carney, J.A. and Stratakis, C.A. (2000) Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). J. Clin. Endocrinol. Metab., 85 3860-3865.
30. Lee, J.S., FitzGibbon, E., Butman, J.A., Dufresne, C.R., Kushner, H., Wientroub, S., Robey, P.G. and Collins, M.T. (2002) Normal vision despite narrowing of the optic canal in fibrous dysplasia. N. Engl. J. Med. Nov., 347, 1670-1676.
31. Kaushik, S., Smoker, W.R. and Frable, W.J. (2002) Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma. Skeletal Radiol., 31, 103-106.
32. Akintoye, S.O., Kelly, M.H., Brillante, B., Cherman, N., Turner, S., Butman, J.A., Robey, P.G. and Collins, M.T. (2006) Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. J. Clin. Endocrinol. Metab., 91, 2960-2966.
33. Galland, F., Kamenicky, P., Affres, H., Reznik, Y., Pontvert, D., Le Bouc, Y., Young, J. and Chanson, P. (2006) McCune-Albright syndrome and acromegaly: Effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J. Clin. Endocrinol. Metab., 91, 4957-4961.
34. Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T.M., Salmela, P.I., Paschke, R. et al. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science, 312, 1228-1230.
35. Ciccarelli, A., Daly, A.F. and Beckers, A. (2005) The epidemiology of prolactinomas. Pituitary, 8, 3-6.
36. Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Valdes-Socin, H., Rohmer, V., Tamburrano, G., Borson-Chazot, C., Estour, B., Ciccarelli, E., Brue, T. et al. (2006) Clinical characterization of familial isolated pituitary adenomas. J. Clin. Endocrinol. Metab., 91 3316-3323.
37. Soares, B.S. and Frohman, L.A. (2004) Isolated familial somatotropinoma. Pituitary, 7, 95-101.
38. Salti, I.S. and Mufarrij, I.S. (1981) Familial cushing disease. Am. J. Med. Genet., 8, 91-94.
39. Pellegata, N.S., Quintanilla-Martinez, L., Siggelkow, H., Samson, E., Bink, K., Hofler, H., Fend, F., Graw, J. and Atkinson, M.J. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl. Acad. Sci. USA, 103 15558-15563.
40. Nadella, K.S. and Kirschner, L.S. (2005) Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res., 65, 10307-10315.
41. Vallar, L., Spada, A. and Giannattasio, G. (1987) Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature, 330, 566-567.
42. Lania, A., Mantovani, G. and Spada, A. (2003) Genetics of pituitary tumors: Focus on G-protein mutations. Exp. Biol. Med. (Maywood), 228, 1004-1017.
43. Weinstein, L.S., Shenker, A., Gejman, P.V., Merino, M.J., Friedman, E. and Spiegel, A.M. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med., 325 1688-1695.
44. Lyons, J., Landis, C.A., Harsh, G., Vallar, L., Grunewald, K., Feichtinger, H., Duh, Q.Y., Clark, O.H., Kawasaki, E., Bourne, H.R. and McCormick, F. (1990) Two G protein oncogenes in human endocrine tumors. Science, 249, 655-659.
45. Williamson, E.A., Daniels, M., Foster, S., Kelly, W.F., Kendall-Taylor, P. and Harris, P.E. (1994) Gs alpha and Gi alpha mutations in clinically non-functioning pituitary tumours. Clin. Endocrinol., 41, 815-820.
46. Gicquel, C., Dib, A., Bertagna, X., Amselem, S. and Le Bouc, Y. (1995) Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis. Eur. J. Endocrinol., 133, 166-172.
47. Shen, Y., Mamers, P., Jobling, T., Burger, H.G. and Fuller, P.J. (1996) Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab., 81, 4159-4161.
48. Petersenn, S., Heyens, M., Ludecke, D.K., Beil, F.U. and Schulte, H.M. (2000) Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas. Clin. Endocrinol. (Oxf. 52, 35-42.
49. Edamatsu, H., Kaziro, Y. and Itoh, H. (1998) Expression of an oncogenic mutant G alpha i2 activates Ras in Rat-1 fibroblast cells. FEBS Lett. 440, 231-234.
50. Dong, Q., Brucker-Davis, F., Weintraub, B.D., Smallridge, R.C., Carr, F.E., Battey, J., Spiegel, A.M. and Shenker, A. (1996) Screening of candidate oncogenes in human thyrotroph tumors: Absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes. J. Clin. Endocrinol. Metab., 81, 1134-1140.
51. Farrell, W.E., Talbot, J.A., Bicknell, E.J., Simpson, D. and Clayton, R.N. (1997) Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas. Clin. Endocrinol. (Oxf.), 47, 241-244.
52. Alvaro, V., Levy, L., Dubray, C., Roche, A., Peillon, F., Querat, B. and Joubert, D. (1993) Invasive human pituitary tumors express a point-mutated alpha-protein kinase C. J. Clin. Endocrinol. Metab., 77, 1125-1129.
53. Schiemann, U., Assert, R., Moskopp, D., Gellner, R., Hengst, K., Gullotta, F., Domschke, W. and Pfeiffer, A. (1997) Analysis of a protein kinase C-mutation in human pituitary tumours. J. Endocrinol., 53, 131-137.
54. Hayward, B.E., Barlier, A., Korbonits, M., Grossman, A.B., Jacquet, P., Enjalbert, A. and Bonthron, D.T. (2001) Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Invest., 107 R31-R36.
55. Mantovani, G., Ballare, E., Giammona, E., Beck-Peccoz, P. and Spada, A. (2002) The Gs gene: Predominant maternal origin of transcription in human thyroid gland and gonads. J. Clin. Endocrinol. Metab., 87 4736-4740.
56. BosNis, I. and Stratakis, C.A. (2004) Minireview: PRKAR1A: normal and abnormal functions. Endocrinology, 145, 5452-5458.
57. Yamasaki, H., Mizusawa, N., Nagahiro, S., Yamada, S., Sano, T., Itakura, M. and Yoshimoto, K. (2003) GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clin. Endocrinol. (Oxf.), 58, 464-470.
58. Sandrini, F., Kirschner, L.S., Bei, T., Farmakidis, C., Yasufuku-Takano, J., Takano, K., Prezant, T.R., Marx, S.J., Farrell, W.E., Clayton, R.N. et al. (2002) PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J. Med. Genet., 39, e78.
59. Kaltsas, G.A., Kola, B., Borboli, N., Morris, D.G., Gueorguiev, M., Swords, F.M., Czirjak, S., Kirschner, L.S., Stratakis, C.A., Korbonits, M. and Grossman, A.B. (2002) Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin. Endocrinol. (Oxf.), 57, 443-448.
60. Esapa, C.T. and Harris, P.E. (1999) Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours. Eur. J. Endocrinol., 141, 409-412.
61. Riminucci, M., Collins, M.T., Lala, R., Corsi, A., Matarazzo, P., Gehron Robey, P. and Bianco, P. (2002) An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma. Mol. Pathol., 55, 58-60.
62. Donangelo, I., Marcos, H.P., Araujo, P.B., Marcondes, J., Filho, P.N., Gadelha, M. and Chimelli, L. (2005) Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas. Endocr. Pathol. Spring, 16, 53-62.
63. Honda, S., Tanaka-Kosugi, C., Yamada, S., Sano, T., Matsumoto, T., Itakura, M. and Yoshimoto, K. (2003) Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene. Endocr. J., 50 309-318.
64. Zhu, J., Leon, S.P., Beggs, A.H., Busque, L., Gilliland, D.G. and Black, P.M. (1994) Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J. Clin. Endocrinol. Metab., 78 922-927.
65. Simpson, D.J., Hibberts, N.A., McNicol, A.M., Clayton, R.N. and Farrell, W.E. (2000) Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res., 60, 1211-1216.
66. Ogino, A., Yoshino, A., Katayama, Y., Watanabe, T., Ota, T., Komine, C., Yokoyama, T. and Fukushima, T. (2005) The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. J. Neuropathol. Exp. Neurol., 64, 398-403.
67. Loffler, K.A., Biondi, C.A., Gartside, M.G., Serewko-Auret, M.M., Duncan, R., Tonks, I.D., Mould, A.W., Waring, P., Muller, H.K., Kay, G.F. and Hayward, N.K. (2007) Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice. Oncogene in press.
68. Takahashi, C., Contreras, B., Iwanaga, T., Takegami, Y., Bakker, A., Bronson, R.T., Noda, M., Loda, M., Hunt, J.L. and Ewen, M.E. (2006) Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Nat. Genet., 38, 118-123.
69. Zhang, X., Sun, H., Danila, D.C., Johnson, S.R., Zhou, Y., Swearingen, B. and Klibanski, A. (2002) Loss of expression of GADD45γ, a growth inhibitory gene, in human pituitary adenomas: Implications for tumorigenesis. J. Clin. Endocrinol. Metab., 87, 1262-1267.
70. Bahar, A., Bicknell, J.E., Simpson, D.J., Clayton, R.N. and Farrell, W.E. (2004) Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation. Oncogene, 23, 936-944.
71. Zhao, J., Dahle, D., Zhou, Y., Zhang, X. and Klibanski, A. (2005) Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J. Clin. Endocrinol. Metab., 90, 2179-2186.
72. Gonsky, R., Herman, V., Melmed, S. and Fagin, J. (1991) Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol. Endocrinol., 5, 1687-1695.
73. Ezzat, S., Zheng, L. and Asa, S.L. (2004) Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia. Mol. Endocrinol., 18, 2543-2552.
74. Yu, S., Asa, S.L., Weigel, R.J. and Ezzat, S. (2003) Pituitary tumor AP-2α recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4. J. Biol. Chem., 278, 19597-19602.
75. Ezzat, S., Yu, S. and Asa, S.L. (2003) Ikaros isoforms in human pituitary tumors: Distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter. Am. J. Pathol., 163, 1177-1184.
76. Ezzat, S., Zheng, L., Zhu, X.F., Wu, G.E. and Asa, S.L. (2002) Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J. Clin. Invest., 109 69-78.
77. McAndrew, J., Paterson, A.J., Asa, S.L., McCarthy, K.J. and Kudlow, J.E. (1995) Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology, 136, 4479-4488.
78. LeRiche, V.K., Asa, S.L., and Ezzat, S. (1996) Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J. Clin. Endocrinol. Metab., 81, 656-662.
79. Yu, R. and Melmed, S. (2004) Pituitary tumor transforming gene: An update. Front Horm. Res., 32, 175-185.
80. Donangelo, I., Gutman, S., Horvath, E., Kovacs, K., Wawrowsky, K., Mount, M. and Melmed, S. (2006) Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 147, 4781-4791.
81. Zou, H., McGarry, T.J., Bernal, T. and Kirschner, M.W. (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science, 285, 418-422.
82. Mei, J., Huang, X. and Zhang, P. (2001) Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts. Curr. Biol., 11, 1197-1201.
83. Hamid, T. and Kakar, S.S. (2004) PTTG/securin activates expression of p53 and modulates its function. Mol. Cancer., 3, 18.
84. McCabe, C.J., Boelaert, K., Tannahill, L.A., Heaney, A.P., Stratford, A.L., Khaira, J.S., Hussain, S., Sheppard, M.C., Franklyn, J.A. and Gittoes, N.J. (2002) Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J. Clin. Endocrinol. Metab., 87, 4238-4244.
85. de la Torre, N.G. and Turner, H.E. (2005) Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour. Pituitary, 8 17-23.
86. Horiguchi, H., Jin, L., Ruebel, K.H., Scheithauer, B.W. and Lloyd, R.V. (2004) Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2 and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF. Endocrine, 24, 141-146.
87. Lombardero, M., Vidal, S., Hurta, R., Roman, A., Kovacs, K., Lloyd, R.V. and Scheithauer, B.W. (2006) Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors. Pituitary, 9, 137-143.
88. Niveiro, M., Aranda, F.I., Peiro, G., Alenda, C. and Pico, A. (2005) Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum. Pathol., 36, 1090-1095.
89. Turner, H.E., Harris, A.L., Melmed, S. and Wass, J.A. (2003) Angiogenesis in endocrine tumors. Endocr. Rev., 24, 600-632.
90. Evans, C.O., Young, A.N., Brown, M.R., Brat, D.J., Parks, J.S., Neish, A.S. and Oyesiku, N.M. (2001) Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J. Clin. Endocrinol. Metab., 86, 3097-3107.
91. Qian, X., Scheithauer, B.W., Kovacs, K. and Lloyd, R.V. (2005) DNA microarrays: Recent developments and applications to the study of pituitary tissues. Endocrine, 28, 49-56.
92. Moreno, C.S., Evans, C.O., Zhan, X., Okor, M., Desiderio, D.M. and Oyesiku, N.M. (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res., 65 10214-10222.
93. Ruebel, K.H., Leontovich, A.A., Jin, L., Stilling, G.A., Zhang, H., Qian, X., Nakamura, N., Scheithauer, B.W., Kovacs, K. and Lloyd, R.V. (2006) Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Endocrine, 29, 435-444.